Eaton Vance Management Spdr Ser Tr Spdr S&P Biotech E Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Eaton Vance Management holds 287,557 shares of XBI stock, worth $25.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

287,557

Previous 256,098 12.28%

Holding current value

$25.8 Million

Previous $19 Million 19.92%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$75.06 - $94.9 $2.36 Million - $2.99 Million	31,459 Added 12.28%	287,557 $22.8 Million
Q2 2022 Aug 15, 2022	BUY	$62.81 - $96.09 $9.22 Million - $14.1 Million	146,790 Added 134.29%	256,098 $19 Million
Q1 2022 May 16, 2022	SELL	$81.07 - $115.44 $5.71 Million - $8.13 Million	-70,383 Reduced 39.17%	109,308 $9.83 Million
Q4 2021 Feb 14, 2022	BUY	$108.77 - $134.15 $252,999 - $312,032	2,326 Added 1.31%	179,691 $19.9 Million
Q3 2021 Nov 15, 2021	BUY	$118.69 - $138.49 $799,495 - $932,868	6,736 Added 3.95%	177,365 $22.2 Million
Q2 2021 Aug 16, 2021	SELL	$122.48 - $139.69 $127,624 - $145,556	-1,042 Reduced 0.61%	170,629 $23.1 Million
Q1 2021 May 17, 2021	BUY	$129.36 - $173.99 $834,501 - $1.12 Million	6,451 Added 3.9%	171,671 $23.3 Million
Q4 2020 Mar 04, 2021	BUY	$110.36 - $151.14 $35,756 - $48,969	324 Added 0.2%	165,220 $23.3 Million
Q4 2020 Feb 12, 2021	SELL	$110.36 - $151.14 $4.03 Million - $5.52 Million	-36,508 Reduced 18.13%	164,896 $23.2 Million
Q3 2020 Nov 13, 2020	SELL	$103.87 - $120.36 $929,740 - $1.08 Million	-8,951 Reduced 4.26%	201,404 $22.4 Million
Q2 2020 Aug 13, 2020	SELL	$73.26 - $114.17 $992,526 - $1.55 Million	-13,548 Reduced 6.05%	210,355 $23.5 Million
Q1 2020 May 14, 2020	BUY	$65.95 - $98.35 $2.57 Million - $3.83 Million	38,911 Added 21.03%	223,903 $17.3 Million
Q4 2019 Feb 11, 2020	BUY	$74.65 - $98.46 $234,251 - $308,967	3,138 Added 1.73%	184,992 $17.6 Million
Q3 2019 Nov 14, 2019	BUY	$76.25 - $83.86 $707,676 - $778,304	9,281 Added 5.38%	181,854 $13.9 Million
Q2 2019 Aug 16, 2019	BUY	N/A	11,536 Added 7.16%	172,573 $15.1 Million
Q1 2019 May 14, 2019	BUY	N/A	50,111 Added 45.18%	161,037 $14.6 Million
Q4 2018 Feb 07, 2019	SELL	N/A	-6,673 Reduced 5.67%	110,926 $7.96 Million
Q3 2018 Nov 13, 2018	BUY	N/A	17,469 Added 17.45%	117,599 $11.3 Million
Q2 2018 Aug 10, 2018	BUY	N/A	13,588 Added 15.7%	100,130 $9.53 Million
Q1 2018 May 07, 2018	BUY	N/A	12,178 Added 16.38%	86,542 $7.59 Million
Q4 2017 Feb 12, 2018	BUY	N/A	38,685 Added 108.43%	74,364 $6.31 Million
Q3 2017 Nov 13, 2017	BUY	N/A	35,679	35,679 $3.09 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Spdr Ser Tr Spdr S&P Biotech E Transaction History